Learn More
Thermo Scientific™ CaptureSelect™ CH1-XL MiniChrom™ Pre-packed Column
Thermo Scientific™ CaptureSelect™ CH1-XL MiniChrom™ columns are designed for bench-scale resin screening, process development, and sample preparation.
Marke: Thermo Scientific™ 5943462005
1281.60 CHF gültig bis 2024-12-20
Benutzen Sie den Promotions-Code "21651" um Ihren Promotions-Preis zu erhalten.
Beschreibung
CaptureSelect CH1-XL MiniChrom™ columns are designed for bench-scale resin screening, process development, and sample preparation.
These pre-packed columns are ready to connect and have the following features:
- Dimensions of 1 mL (0.8 x 2 cm) and 5 mL (0.8 x 10 cm)
- Direct connection to standard chromatography systems
- Packed with CaptureSelect CH1-XL Affinity Matrix, offering high dynamic binding capacity and high resolution over a wide range of flow rates
The 1 mL columns can be used for quick screenings of application feasibility and lab scale purification on a convenient and easy-to-use pre-packed column. The 10 cm bed height of the 5 mL columns allows initial process development on a bench scale.
The CaptureSelect CH1-XL Affinity Matrix recognizes the CH1 domain of human IgG antibodies, thereby enabling purification of all Fab fragments, independent of the light-chain type (kappa or lambda) and without binding of over-expressed light chain and light-chain dimers. In addition, it can be used for the purification of human IgGs from all four subclasses (1, 2, 3, and 4).
Features of this affinity matrix include:
- Platform approach for purification of high quality and correctly assembled human Fab fragments
- No co-purification of over-expressed free light chains due to selectivity for the CH1 domain
- Elution possible at pH 4.0–4.5 with 50 mM acetate buffer
- Caustic cleaning with up to 50 mM NaOH
- Excellent scalability
- No cross binding to bovine IgG, therefore presence of fetal bovine serum is not a problem
Free of animal components
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12 to 15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).
Main characteristics:
- Matrix: agarose-based, epoxide-activated
- Average particle size: 65 ± 10 μm
- Ligand: CaptureSelect CH1-XL affinity ligand
- Ligand coupling method: epoxide coupling
- Binding capacity: >15 mg/mL human Fab fragment, depending on flow rate, column height, and contact time. Note that humanized Fab fragments may have lower capacities.
- Elution conditions: 100 mM glycine buffer, pH 3.0; 50 mM acetate buffer, pH 4.0 - 4.5
- Column dimensions: 1 mL (0.8 x 2 cm) and 5 mL (0.8 x 10 cm)
- Flow characteristics: 75–150 cm/h (up to 2 bar)
- Formulation buffer: 20%(v/v) ethanol
Spezifikation
Chromatography Cartridge | |
75 to 150 cm/hr. (Up to 2 bar) | |
CH1-XL affinity ligand | |
CaptureSelect CH1-XL affinity ligand | |
CaptureSelect | |
Zugelassen für den Versand bei Raumtemperatur oder auf nassem Eis | |
5 mL |
0.8 cm | |
10 cm | |
65 ± 10 μm | |
Store in refrigerator (2°C to 8°C). | |
>15 mg/mL human Fab fragment | |
Agarose-based, epoxide-activated |
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.